Role of transforming growth factor-beta(1) and -beta(2) in ddY mouse nephropathy

被引:2
|
作者
Ye, XF [1 ]
Yorioka, N [1 ]
Oda, H [1 ]
Taniguchi, Y [1 ]
Yamakido, M [1 ]
机构
[1] HIROSHIMA UNIV, SCH MED, DEPT INTERNAL MED 2, MINAMI KU, HIROSHIMA 734, JAPAN
关键词
ddY mice; transforming growth factor-beta(1); transforming growth factor-beta(2); IGA nephropathy; mesangial matrix expansion;
D O I
10.1177/030006059702500304
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We investigated the glomerular distribution of transforming growth factor-beta (TGF-beta(1) and TGF-beta(2)) protein and the expression of its mRNA, and related factors, in ddY mice, aged 5 - 60 weeks, before and after the onset of nephropathy. TGF-beta(1) protein expression was observed from the age of 20 weeks onwards, peaking at 50 weeks, and then declining. Expression of TGF-beta(2) protein gradually increased from 5 to 60 weeks. TGF-beta(1) and TGF-beta(2) mRNA were both detected from 5 to 60 weeks. The mesangial matrix expansion index (MMEI) was significantly higher in mice with nephropathy than in those without nephropathy, as was the expression of TGF-beta(1) and TGF-beta(2) proteins (P < 0.05). TGF-beta(2) was significantly positively correlated with the MMEI (P < 0.05). Infiltration of CD68-positive monocytes/macrophages gradually increased until 60 weeks, and was significantly correlated with the expression of TGF-beta(1) (P < 0.05) and TGF-beta(2) (P < 0.01). These findings indicate that TGF-beta(1) and TGF-beta(2) were overexpressed in ddY mice with overt nephropathy compared with pre-nephropathic mice. TGF-beta(2) may be an important mediator of mesangial matrix expansion in ddY mouse nephropathy.
引用
收藏
页码:141 / 154
页数:14
相关论文
共 50 条
  • [31] Ocular toxicity of intravitreous transforming growth factor-beta 1
    Liang, CP
    Peyman, GA
    Federman, J
    [J]. EYE, 1996, 10 : 709 - 713
  • [32] Transforming growth factor-beta and prostate cancer
    Steiner, MS
    [J]. WORLD JOURNAL OF UROLOGY, 1995, 13 (06) : 329 - 336
  • [33] DEACTIVATION OF MACROPHAGES BY TRANSFORMING GROWTH FACTOR-BETA
    TSUNAWAKI, S
    SPORN, M
    DING, A
    NATHAN, C
    [J]. NATURE, 1988, 334 (6179) : 260 - 262
  • [34] Transforming growth factor-beta signal transduction
    Brand, T
    Schneider, MD
    [J]. CIRCULATION RESEARCH, 1996, 78 (02) : 173 - 179
  • [35] Transforming growth factor-beta (TGF-β)
    Clark, DA
    Coker, R
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1998, 30 (03): : 293 - 298
  • [36] Transforming growth factor-beta(1) in chronic hepatitis C
    Nelson, DR
    GonzalezPeralta, RP
    Qian, K
    Xu, Y
    Marousis, CG
    Davis, GL
    Lau, JYN
    [J]. JOURNAL OF VIRAL HEPATITIS, 1997, 4 (01) : 29 - 35
  • [37] STIMULATION OF TRANSFORMING GROWTH FACTOR-BETA(1) TRANSCRIPTION BY CYCLOSPORINE
    PRASHAR, Y
    KHANNA, A
    SEHAJPAL, P
    SHARMA, VK
    SUTHANTHIRAN, M
    [J]. FEBS LETTERS, 1995, 358 (02) : 109 - 112
  • [38] DISTRIBUTION OF TRANSFORMING GROWTH FACTOR-BETA(1) IN HUMAN ASTROCYTOMAS
    HORST, HA
    SCHEITHAUER, BW
    KELLY, PJ
    KOVACH, JS
    [J]. HUMAN PATHOLOGY, 1992, 23 (11) : 1284 - 1288
  • [39] Transforming growth factor-beta: A general review
    Lawrence, DA
    [J]. EUROPEAN CYTOKINE NETWORK, 1996, 7 (03) : 363 - 374
  • [40] Transforming growth factor-beta in in vivo resistance
    Teicher, BA
    Holden, SA
    Ara, G
    Chen, G
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 37 (06) : 601 - 609